Admedus Archives - Cardiovascular News

ADVERTORIAL: Answering the question of durability is TAVI’s next challenge

17th November 2019

Over the past few yea...

ECHSA 2019: Shape matters and is an innovation

12th September 2019

Martin Kostelka (Leip...

CardioCel benefits patients with different anatomies for intracardiac application

2nd September 2019

Speaking to Cardiovas...

CardioCel 500—Long term experience with no calcification

27th August 2019

Giovanni Stellin (Pad...

CardioCel use improves management of critically ill neonates

9th August 2019

Tomasz Mroczek (Krak...

ECHSA 2019: CardioCel acellular bioscaffold handles well

30th July 2019

Caner Salih (London, ...

Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold

27th June 2019

Admedus has announced...

CardioCel 3D and VascuCel receive regulatory approval in Europe

15th March 2019

Admedus has received ...

CardioCel now approved for use in the UAE

22nd November 2016

Admedus has announced...

Long-term study indicates no calcification with CardioCel after eight years

22nd August 2016

Long-term data from a...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy